Sunshine Biopharma (SBFM) Retained Earnings (2010 - 2026)
Sunshine Biopharma (SBFM) reported Retained Earnings of -$76.3 million for Q1 2026, down 8.6% on a YoY basis from -$83.4 million in Q1 2025, and down 116666.44% quarter-over-quarter from -$65309.0 in Q4 2025.
Sunshine Biopharma (SBFM) Retained Earnings (2010 - 2026) Analysis & Trends
Sunshine Biopharma has reported Retained Earnings for 16 years, with the latest figure at -$76.3 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 8.6% year-over-year to -$76.3 million; the trailing twelve-month figure through Mar 2026 stood at -$76.3 million (down 8.6% YoY), and the FY2025 full-year result was -$65309.0, up 92.13% from the prior year.
- Retained Earnings for Q1 2026 stood at -$76.3 million, down from -$65309.0 in the prior quarter.
- The five-year high for Retained Earnings was $696105.0 in Q4 2023, with the low at -$76.3 million in Q1 2026.
- Historically, Retained Earnings has averaged -$20.7 million across 5 years, with a median of -$79903.0 in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 799.46% — and 2025, when it tumbled 46175.82%.
- Sunshine Biopharma's Retained Earnings stood at $161847.0 in 2022, then soared by 330.1% to $696105.0 in 2023, then sank by 219.23% to -$829959.0 in 2024, then surged by 92.13% to -$65309.0 in 2025, then slumped by 116666.44% to -$76.3 million in 2026.
- The last three Retained Earnings figures came in at -$76.3 million (Q1 2026), -$65309.0 (Q4 2025), and -$320841.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | -76.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.26 Mn |
| Dec 31, 2025 | -65,309.00 |
| Sep 30, 2025 | -320,841.00 |
| Jun 30, 2025 | -71.99 Mn |
| Mar 31, 2025 | -70.22 Mn |
| Dec 31, 2024 | -829,959.00 |
| Sep 30, 2024 | 168,590.00 |
| Jun 30, 2024 | -65.68 Mn |
| Mar 31, 2024 | 152,400.00 |
| Dec 31, 2023 | 696,105.00 |
| Sep 30, 2023 | 204,549.00 |
| Jun 30, 2023 | 665,056.00 |
| Mar 31, 2023 | 173,007.00 |
| Dec 31, 2022 | 161,847.00 |
| Sep 30, 2022 | -79,903.00 |
| Jun 30, 2022 | -34.43 Mn |
| Mar 31, 2022 | -33.89 Mn |
| Dec 31, 2021 | -23,139.00 |
| Sep 30, 2021 | -33.32 Mn |
| Jun 30, 2021 | -29.28 Mn |